It is shown that breast cancer metastases differ in their capacity for secondary seeding: the liver fosters metastasis-promoting properties and boosts secondary spread, whereas the lung restricts these processes, favoring local growth.
Abstract
Breast cancer progression to visceral organs such as the lung and liver is associated with poor prognosis. Yet, these organs have diverse cellular microenvironments that may differentially influence cancer cell behavior. Here, we show that breast cancer metastases differ in their capacity for secondary seeding: the liver fosters metastasis-promoting properties and boosts secondary spread, whereas the lung restricts these processes, favoring local growth. Using patient data and rapid autopsy tissues, mouse models with barcode-mediated tracing, niche-labeling technology, and single-cell analysis of tumor cells and their direct microenvironment, we dissect the cellular and molecular microenvironmental factors underlying this differential behavior. Mechanistically, we identify BMP2-producing endothelial cells as critical players within the liver metastatic niche, enhancing metastasis-to-metastasis dissemination. Targeting the BMP2 signaling axis suppresses secondary spread of liver-derived breast cancer lesions. Altogether, we reveal site-specific behavior of lung and liver metastases in breast cancer, highlighting microenvironmental mechanisms and therapeutic opportunities for intervention.
Overall, single-cell and spatial multi-omics are reframing breast cancer metastasis as a dynamic, multi-stage, and tissue-shaped process, providing a foundation for future biomarker development and mechanism-guided therapeutic strategies.
Yang Qu, Juan Sun, Zi-Hao Wang et al.· Biochimica et biophysica act...· 0 citations
The findings reveal distinct metastatic microenvironments in liver and lung characterized by coordinated differences in tumor subtype composition and myeloid phenotype, highlighting the importance of local immune landscapes in shaping metastatic disease biology.
E. Lasse-Opsahl, Daksh Thakkar, Julie M. Clark et al.· Cancer Research· 0 citations
The liver-specific biological basis of immunotherapy resistance in colorectal cancer liver metastasis is summarized, focusing on three interconnected mechanistic layers, including the pre-existing tolerogenic immune niche of the liver, the local immunosuppressive microenvironment established within liver metastases, an...
Zi-Jing Liu, Jia Liu, Sheng-Shan Xu et al.· Frontiers in Immunology· 0 citations
The main characteristics of the liver's immune microenvironment are organized and discussed, with a focus on immunotherapy, anti-angiogenic therapy, and convergent therapy strategies involving emerging targets such as human epidermal growth factor receptor 2 and claudin-18.
L.-X. Shen, W.-J. Fang, Z. Tong· Zhonghua gan zang bing za zh...· 0 citations
These findings uncover CAF–bone-marrow cross-talk as a therapeutic target linking stromal inflammation, immune remodeling, and metastatic progression as a therapeutic target linking stromal inflammation, immune remodeling, and metastatic progression.
Yasuto Takeuchi, Hua-Zi Zhang, T. Murayama et al.· bioRxiv· 0 citations
A framework in which metastasis is dynamically codetermined by tumor cell plasticity and host systemic state is described, contextualized by recent mechanistic insights into how lifestyle and physiological states rewire organ microenvironments to become either permissive or restrictive to metastatic colonization is des...
Gwennan Ward, Álvaro Ruiz-Tabas, P. Altea-Manzano· FEBS Letters· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.